$Poly({varepsilon}-carbobenzoxy;L-lysine)/poly(ethylene oxide)/poly({varepsilon}-carbobenzoxy;L-lysine)$ (LEL) block copolymers containing $poly({varepsilon}-carbobenzoxy;L-lysine)$ (PCLL) as the A component and poly(ethylene oxide) (PEO) as the B component were investigated as drug delivery matrix. PCLL homopolymer and LEL block copolymer microspheres containing anticancer drug, cytarabine, were prepared by a solvent evaporation process and the release patterns of cytarabine from the microspheres were investigated in vitro. The size of PCLL homopolymer and LEL block copolymer microspheres was ranged from $0.2;{mu}m$ to $1;{mu}m$ in diameter and the shape of the microspheres was almost round. The release pattern of cytarabine from the block copolymer microspheres was dependent on the mole % of PEO of the block copolymers.